Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Zeev Estrov Guillermo Garcia-Manero Srdan Verstovsek Jorge Eduardo Cortes Hagop Kantarjian Taghi Manshouri |
| Publication date | December 11, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |